The Neutrophil-to-Lymphocyte Ratio (NLR) Predicts the Prognosis of Unresectable Intermediate and Advanced Hepatocellular Carcinoma Treated with Apatinib

PURPOSE: Patients with hepatocellular carcinoma (HCC) who might benefit most from anti-angiogenesis therapy remain unknown. In recent years, neutrophil-to-lymphocyte ratio (NLR), an indicator of inflammatory response, has received particular attention in HCC. Herein, we explored the prognostic value...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Huaqi, Wang, Zhiwei, Hou, Zhenyu, Yang, Xuejiao, Zhu, Keyun, Cao, Manqing, Zhu, Xiaolin, Li, Huikai, Zhang, Ti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434860/
https://www.ncbi.nlm.nih.gov/pubmed/34522141
http://dx.doi.org/10.2147/CMAR.S311526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8434860/
https://www.ncbi.nlm.nih.gov/pubmed/34522141
http://dx.doi.org/10.2147/CMAR.S311526

Ejemplares similares